Emergent BioSolutions Inc. (EBS) › Weighted Average Diluted SharesEmergent BioSolutions Inc. (EBS) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2009-12-31: 31.38M2010-12-31: 32.54M2011-12-31: 36.21M2012-12-31: 36.42M2013-12-31: 36.75M2014-12-31: 45.80M2015-12-31: 47.26M2016-12-31: 49.30M2017-12-31: 50.30M2018-12-31: 51.40M2019-12-31: 52.40M2020-12-31: 53.80M2021-12-31: 54.10M2022-12-31: 50.10M2023-12-31: 51.20M2024-12-31: 53.00M2025-12-31: 56.70M56.70M2009-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3156.70M+7.0%2026-02-27From 2025-01-012024-12-3153.00M+3.5%2026-02-27From 2024-01-012023-12-3151.20M+2.2%2026-02-27From 2023-01-012022-12-3150.10M-7.4%2025-03-04From 2022-01-012021-12-3154.10M+0.6%2024-03-08From 2021-01-012020-12-3153.80M+2.7%2023-12-11From 2020-01-012019-12-3152.40M+1.9%2022-02-25From 2019-01-012018-12-3151.40M+2.2%2021-02-19From 2018-01-012017-12-3150.30M+2.0%2020-02-25From 2017-01-012016-12-3149.30M+4.3%2019-02-22From 2016-01-012015-12-3147.26M+3.2%2018-02-23From 2015-01-012014-12-3145.80M+24.6%2017-02-28From 2014-01-012013-12-3136.75M+0.9%2016-02-29From 2013-01-012012-12-3136.42M+0.6%2015-03-09From 2012-01-012011-12-3136.21M+11.3%2014-03-10From 2011-01-012010-12-3132.54M+3.7%2013-03-08From 2010-01-012009-12-3131.38M—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)